Calliditas Therapeutics Ab (CALT) Stock Price, News & Analysis
Company Description
Calliditas Therapeutics Ab (NASDAQ: CALT) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector and carries a market capitalization of $1.1B, ranking #2,891 among all listed U.S. companies by market cap.
CALT has gained 144.2% over the past year. Shares last traded at $40.00.
This page collects what Stock Titan holds for CALT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Calliditas Therapeutics Ab (CALT) stock last closed at $40.00. Over the past 12 months, the stock has gained 144.2%. At a market capitalization of $1.1B, CALT is classified as a small-cap stock.
CALT Rankings
Latest News
Calliditas Therapeutics Ab has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, clinical trial. View all CALT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CALT Company Profile & Sector Positioning
Calliditas Therapeutics Ab (CALT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.